These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1291362)

  • 1. The specific plaque hypothesis and the antimicrobial treatment of periodontal disease.
    Loesche WJ
    Dent Update; 1992 Mar; 19(2):68, 70-2, 74. PubMed ID: 1291362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial approaches to periodontal therapy].
    Vitaya CT
    J Dent Assoc Thai; 1990; 40(2):83-91. PubMed ID: 2074322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic use of antimicrobial agents in patients with periodontal disease.
    Loesche WJ
    Scand J Infect Dis Suppl; 1985; 46():106-14. PubMed ID: 3865349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possibilities for treating periodontal disease as specific anaerobic infections.
    Loesche WJ
    J Can Dent Assoc; 1984 Jun; 50(6):467-72. PubMed ID: 6378336
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Treatment of periodontal diseases with metronidazole (J Periodontol 1993;64:1-15).
    Peros WJ
    J Periodontol; 1993 Sep; 64(9):918-20. PubMed ID: 8229632
    [No Abstract]   [Full Text] [Related]  

  • 6. The benzoyl-DL arginine-naphthylamide (BANA) test and polymerase chain reaction measurement of pathogenic bacteria can assess the severity of periodontal disease.
    Takaishi Y; Morii H; Miki T
    Int J Tissue React; 2003; 25(1):19-24. PubMed ID: 12854883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dental plaque revisited: bacteria associated with periodontal disease.
    Lovegrove JM
    J N Z Soc Periodontol; 2004; (87):7-21. PubMed ID: 15143484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of metronidazole in the treatment of periodontal diseases.
    Ghayoumi N
    J West Soc Periodontol Periodontal Abstr; 2001; 49(2):37-40. PubMed ID: 11521352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks.
    Loesche WJ; Syed SA; Morrison EC; Kerry GA; Higgins T; Stoll J
    J Periodontol; 1984 Jun; 55(6):325-35. PubMed ID: 6376759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of anaerobic bacteria in periodontal disease.
    Loesche WJ
    Ann Otol Rhinol Laryngol Suppl; 1991 Sep; 154():43-5. PubMed ID: 1952684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gingival plaque anaerobic bacteria in periodontal disease].
    Peret R
    Bull Acad Natl Chir Dent; 1988; 34(34):195-207. PubMed ID: 3274093
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a diagnostic test for anaerobic periodontal infections based on plaque hydrolysis of benzoyl-DL-arginine-naphthylamide.
    Loesche WJ; Bretz WA; Kerschensteiner D; Stoll J; Socransky SS; Hujoel P; Lopatin DE
    J Clin Microbiol; 1990 Jul; 28(7):1551-9. PubMed ID: 2380379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination].
    Mouton C; Dextraze L; Mayrand D
    J Biol Buccale; 1984 Mar; 12(1):17-26. PubMed ID: 6584423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of the BANA test for monitoring anaerobic infections due to spirochetes (Treponema denticola) in periodontal disease.
    Loesche WJ; Giordano J; Hujoel PP
    J Dent Res; 1990 Oct; 69(10):1696-702. PubMed ID: 2212216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy. A viable periodontal treatment modality?
    Deasy MJ
    Dent Clin North Am; 1990 Jan; 34(1):1-11. PubMed ID: 2403938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in periodontal diagnosis. 4. Potential microbiological markers.
    Eley BM; Cox SW
    Br Dent J; 1998 Feb; 184(4):161-6. PubMed ID: 9549909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic and anaerobic bacteria in subgingival and supragingival plaques of adult patients with periodontal disease.
    Daniluk T; Tokajuk G; Cylwik-Rokicka D; Rozkiewicz D; Zaremba ML; Stokowska W
    Adv Med Sci; 2006; 51 Suppl 1():81-5. PubMed ID: 17458065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic metronidazole therapy and/or subgingival scaling and root planing. II. Development of clinical parameters in relation to the changes in the composition of the associated subgingival microflora].
    Hartmann J; Müller HP; Flores-de-Jacoby L
    Dtsch Zahnarztl Z; 1986 Jun; 41(6):579-84. PubMed ID: 3527679
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of metronidazole in the treatment of periodontal diseases.
    Greenstein G
    J Periodontol; 1993 Jan; 64(1):1-15. PubMed ID: 8426284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial action of AXOL on periodontopathic bacteria.
    Bretz WA; Salvador SL
    Braz Dent J; 1993; 4(1):49-52. PubMed ID: 8180485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.